3,4′,5-trans-Trimethoxystilbene; A natural analogue of resveratrol with enhanced anticancer potency

Investigational New Drugs

Volumn 33, Issue 3, 2015, Pages 775-786

  Aldawsari, Fahad S ^a   Velázquez Martínez, Carlos A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Anticancer; Antioxidant; Chemoprevention; In vivo; Prostate cancer; Resveratrol analogues

Indexed keywords

3,4',5-TRIMETHOXYSTILBENE; ANTINEOPLASTIC AGENT; ANTIOXIDANT; RESVERATROL; SCAVENGER; STILBENE DERIVATIVE;

ANIMAL; APOPTOSIS; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; DRUG SCREENING; HUMAN; IC50; METABOLISM; METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PATHOLOGY; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; FREE RADICAL SCAVENGERS; HUMANS; INHIBITORY CONCENTRATION 50; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STILBENES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84939986664     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-015-0222-x     Document Type: Review

References (105)

1. Harikumar KB, Aggarwal BB (2008) Resveratrol: A multitargeted agent for age-associated chronic diseases. Cell Cycle 7(8):1020-1035
2. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW et al (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275(5297):218-220
3. Koeberle A, Werz O (2014) Multi-target approach for natural products in inflammation. Drug Discov Today 19(12):1871-1882
4. Tang PC, Ng YF, Ho S, Gyda M, Chan SW (2014) Resveratrol and cardiovascular health-promising therapeutic or hopeless illusion? Pharmacol Res 90:88-115
5. Farris P, Krutmann J, Li YH, McDaniel D, Krol Y (2013) Resveratrol: a unique antioxidant offering a multi-mechanistic approach for treating aging skin. J Drugs Dermatol 12(12):1389-1394
6. Kasiotis KM, Pratsinis H, Kletsas D, Haroutounian SA (2013) Resveratrol and related stilbenes: Their anti-aging and anti-angiogenic properties. Food Chem Toxicol 61:112-120
7. Tome-Carneiro J, Larrosa M, Gonzalez-Sarrias A, Tomas-Barberan FA, Garcia-Conesa MT, Espin JC (2013) Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr Pharm Des 19(34):6064-6093
8. Scott E, Steward WP, Gescher AJ, Brown K (2012) Resveratrol in human cancer chemoprevention - Choosing the 'right' dose. Mol Nutr Food Res 56(1):7-13
9. Signorelli P, Ghidoni R (2005) Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. J Nutr Biochem 16(8):449-466
10. Delmas D, Aires V, Limagne E, Dutartre P, Mazué F, Ghiringhelli F et al (2011) Transport, stability, and biological activity of resveratrol. Ann N Y Acad Sci 1215(1):48-59
11. Cottart CH, Nivet-Antoine V, Beaudeux JL (2014) Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans. Mol Nutr Food Res 58(1):7-21
12. Smoliga J, Blanchard O (2014) Enhancing the delivery of resveratrol in humans: if Low bioavailability is the problem, what is the solution? Molecules 19(11):17154-17172
13. Pangeni R, Sahni JK, Ali J, Sharma S, Baboota S (2014) Resveratrol: review on therapeutic potential and recent advances in drug delivery. Expert Opin Drug Deliv 11(8):1285-1298
14. H-s L, Ho PC (2011) Preclinical pharmacokinetic evaluation of resveratrol trimethyl ether in sprague-dawley rats: the impacts of aqueous solubility, dose escalation, food and repeated dosing on oral bioavailability. J Pharm Sci 100(10):4491-4500
15. Wang TT, Schoene NW, Kim YS, Mizuno CS, Rimando AM (2010) Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res 54(3):335-344
16. Weng C-J, Yang Y-T, Ho C-T, Yen G-C (2009) Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells. J Agric Food Chem 57(12):5235-5243
17. Yang Y-T, Weng C-J, Ho C-T, Yen G-C (2009) Resveratrol analog-3,5,4′-trimethoxy-trans-stilbene inhibits invasion of human lung adenocarcinoma cells by suppressing the MAPK pathway and decreasing matrix metalloproteinase-2 expression. Mol Nutr Food Res 53(3):407-416
18. Bader Y, Madlener S, Strasser S, Maier S, Saiko P, Stark N et al (2008) Stilbene analogues affect cell cycle progression and apoptosis independently of each other in an MCF-7 array of clones with distinct genetic and chemoresistant backgrounds. Oncol Rep 19(3):801-810
19. Li L, Xiu-Ju L, Ying-Zi L, Yi-Shuai Z, Qiong Y, Na T et al (2010) The role of the DDAH-ADMA pathway in the protective effect of resveratrol analog BTM-0512 on gastric mucosal injury. Can J Physiol Pharmacol 88(5):562-567
20. Dias SJ, Li K, Rimando AM, Dhar S, Mizuno CS, Penman AD et al (2013) Trimethoxy-resveratrol and piceatannol administered orally suppress and inhibit tumor formation and growth in prostate cancer xenografts. Prostate 73(11):1135-1146
21. Rivera H, Shibayama M, Tsutsumi V, Perez-Alvarez V, Muriel P (2008) Resveratrol and trimethylated resveratrol protect from acute liver damage induced by CCl4 in the rat. J Appl Toxicol 28(2):147-155
22. Liu B, Luo XJ, Yang ZB, Zhang JJ, Li TB, Zhang XJ et al (2014) Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats. J Cardiovasc Pharmacol 63(6):567-576
23. Kim DW, Kim YM, Kang SD, Han YM, Pae HO (2012) Effects of resveratrol and trans-3,5,4′-trimethoxystilbene on glutamate-induced cytotoxicity, heme oxygenase-1, and sirtuin 1 in HT22 neuronal cells. Biomol Ther (Seoul) 20(3):306-312
24. Blair GE, Cassady JM, Robbers JE, Tyler VE, Raffauf RF (1969) Isolation of 3,4′,5-trimethoxy-trans-stilbene, otobaene and hydroxyotobain from Virola cuspidata. Phytochemistry 8(2):497-500
25. MacRae WD, Towers GHN (1985) Non-alkaloidal constituents of Virola elongata bark. Phytochemistry 24(3):561-566
26. Abdel-Mogib M, Basaif SA, Sobahi TR (2001) Stilbenes and a new acetophenone derivative from Scirpus holoschoenus. Molecules 6(8):663-667
27. Kumar RJ, Jyostna D, Krupadanam GLD, Srimannarayana G (1988) Phenanthrene and stilbenes from pterolobium-hexapetallum. Phytochemistry 27(11):3625-3626
28. Anjaneyulu ASR, Reddy AVR, Reddy DSK, Ward RS, Adhikesavalu D, Cameron TS (1984) Pacharin - a New dibenzo (2,3-6,7) oxepin derivative from bauhinia-racemosa lamk. Tetrahedron 40(21):4245-4252
29. Coulerie P, Eydoux C, Hnawia E, Stuhl L, Maciuk A, Lebouvier N et al (2012) Biflavonoids of dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase. Planta Med 78(7):672-677
30. Kim DH, Kim JH, Baek SH, Seo JH, Kho YH, Oh TK et al (2004) Enhancement of tyrosinase inhibition of the extract of Veratrum patulum using cellulase. Biotechnol Bioeng 87(7):849-854
31. Belofsky G, Percivill D, Lewis K, Tegos GP, Ekart J (2004) Phenolic metabolites of Dalea versicolor that enhance antibiotic activity against model pathogenic bacteria. J Nat Prod 67(3):481-484
32. Zaki MA, Balachandran P, Khan S, Wang M, Mohammed R, Hetta MH et al (2013) Cytotoxicity and modulation of cancer-related signaling by (Z)- and (E)-3,4,3′,5′-tetramethoxystilbene isolated from Eugenia rigida. J Nat Prod 76(4):679-684
33. Ehrhardt C, Arapitsas P, Stefanini M, Flick G, Mattivi F (2014) Analysis of the phenolic composition of fungus-resistant grape varieties cultivated in Italy and Germany using UHPLC-MS/MS. J Mass Spectrom 49(9):860-869
34. Chaher N, Arraki K, Dillinseger E, Temsamani H, Bernillon S, Pedrot E et al (2014) Bioactive stilbenes from Vitis vinifera grapevine shoots extracts. J Sci Food Agric 94(5):951-954
35. Xie L, Bolling BW (2014) Characterisation of stilbenes in California almonds (Prunus dulcis) by UHPLC-MS. Food Chem 148:300-306
36. Sales JM, Resurreccion AVA (2013) Resveratrol in peanuts. Crit Rev Food Sci Nutr 54(6):734-770
37. Lopes RM, Agostini-Costa TS, Gimenes MA, Dm S (2011) Chemical composition and biological activities of arachis species. J Agric Food Chem 59(9):4321-4330
38. Alonso F, Riente P, Yus M (2009) Synthesis of resveratrol, DMU-212 and analogues through a novel Wittig-type olefination promoted by nickel nanoparticles. Tetrahedron Lett 50(25):3070-3073
39. Farina A, Ferranti C, Marra C, Guiso M, Norcia G (2007) Synthesis of hydroxystilbenes and their derivatives via Heck reaction. Nat Prod Res 21(6):564-573
40. Das J, Pany S, Majhi A (2011) Chemical modifications of resveratrol for improved protein kinase C alpha activity. Bioorg Med Chem 19(18):5321-5333
41. Solladié G, Pasturel-Jacopé Y, Maignan J (2003) A re-investigation of resveratrol synthesis by Perkins reaction. Application to the synthesis of aryl cinnamic acids. Tetrahedron 59(18):3315-3321
42. Yoo KM, Kim S, Moon BK, Kim SS, Kim KT, Kim SY et al (2006) Potent inhibitory effects of resveratrol derivatives on progression of prostate cancer cells. Arch Pharm 339(5):238-241
43. Kumar A, Lin S-Y, Dhar S, Rimando AM, Levenson AS (2014) Stilbenes inhibit androgen receptor expression in 22Rv1 castrate-resistant prostate cancer cells. J Medicinally Active Plants 3(1):1-8
44. Cardile V, Chillemi R, Lombardo L, Sciuto S, Spatafora C, Tringali C (2007) Antiproliferative activity of methylated analognes of E- and Z-resveratrol. Z Naturforsch C 62(3-4):189-195
45. Gosslau A, Pabbaraja S, Knapp S, Chen KY (2008) Trans- and cis-stilbene polyphenols induced rapid perinuclear mitochondrial clustering and p53-independent apoptosis in cancer cells but not normal cells. Eur J Pharmacol 587(1-3):25-34
46. Shi L, Huang XF, Zhu ZW, Li HQ, Xue JY, Zhu HL et al (2008) Synthesis of alpha-aminoalkyl phosphonate derivatives of resveratrol as potential antitumour agents. Aust J Chem 61(6):472-475
47. Lee S, Nam K, Hoe Y, Min H-Y, Kim E-Y, Ko H et al (2003) Synthesis and evaluation of cytotoxicity of stilbene analogues. Arch Pharm Res 26(4):253-257
48. Paul S, Mizuno CS, Lee HJ, Zheng X, Chajkowisk S, Rimoldi JM et al (2010) In vitro and in vivo studies on stilbene analogs as potential treatment agents for colon cancer. Eur J Med Chem 45(9):3702-3708
49. Mazue F, Colin D, Gobbo J, Wegner M, Rescifina A, Spatafora C et al (2010) Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs. Eur J Med Chem 45(7):2972-2980
50. Minutolo F, Sala G, Bagnacani A, Bertini S, Carboni I, Placanica G et al (2005) Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. J Med Chem 48(22):6783-6786
51. Zhang W, Go ML (2011) Methoxylation of resveratrol: Effects on induction of NAD (P) H Quinone-oxidoreductase 1 (NQO1) activity and growth inhibitory properties. Bioorg Med Chem Lett 21(3):1032-1035
52. Ruan B-F, Lu X, Tang J-F, Wei Y, Wang X-L, Zhang Y-B et al (2011) Synthesis, biological evaluation, and molecular docking studies of resveratrol derivatives possessing chalcone moiety as potential antitubulin agents. Bioorg Med Chem 19(8):2688-2695
53. Chen Y, Hu F, Gao Y, Jia S, Ji N, Hua E (2013) Design, synthesis, and evaluation of methoxylated resveratrol derivatives as potential antitumor agents. Res Chem Intermed:1-14
54. Pettit GR, Grealish MP, Jung MK, Hamel E, Pettit RK, Chapuis JC et al (2002) Antineoplastic agents. 465. Structural modification of resveratrol: sodium resverastatin Phosphate1. J Med Chem 45(12):2534-2542
55. Simoni D, Roberti M, Invidiata FP, Aiello E, Aiello S, Marchetti P et al (2006) Stilbene-based anticancer agents: Resveratrol analogues active toward HL60 leukemic cells with a non-specific phase mechanism. Bioorg Med Chem Lett 16(12):3245-3248
56. Tolomeo M, Grimaudo S, Di Cristina A, Roberti M, Pizzirani D, Meli M et al (2005) Pterostilbene and 3′-hydroxypterostilbene are effective apoptosis-inducing agents in MDR and BCR-ABL-expressing leukemia cells. Int J Biochem Cell Biol 37(8):1709-1726
57. Deng Y-H, Alex D, Huang H-Q, Wang N, Yu N, Wang Y-T et al (2011) Inhibition of TNF-α-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3,5,4′-trimethoxystilbene. Phytother Res 25(3):451-457
58. Belleri M, Ribatti D, Nicoli S, Cotelli F, Forti L, Vannini V et al (2005) Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′-trimethoxystilbene. Mol Pharmacol 67(5):1451-1459
59. Morris V, Toseef T, Nazumudeen F, Rivoira C, Spatafora C, Tringali C, et al (2015) Anti-tumor properties of cis-resveratrol methylated analogs in metastatic mouse melanoma cells. Mol Cell Biochem:1-9
60. Calabrese EJ, Mattson MP, Calabrese V (2010) Resveratrol commonly displays hormesis: Occurrence and biomedical significance. Hum Exp Toxicol 29(12):980-1015
61. Su D, Cheng Y, Liu M, Liu D, Cui H, Zhang B et al (2013) Comparision of piceid and resveratrol in antioxidation and antiproliferation activities in vitro. PLoS One 8(1):e54505
62. Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou Y et al (2014) Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/beta-catenin signaling pathway. PLoS One 9(7):e102535
63. Mohapatra P, Satapathy SR, Das D, Siddharth S, Choudhuri T, Kundu CN (2014) Resveratrol mediated cell death in cigarette smoke transformed breast epithelial cells is through induction of p21Waf1/Cip1 and inhibition of long patch base excision repair pathway. Toxicol Appl Pharmacol 275(3):221-231
64. Sareen D, Darjatmoko SR, Albert DM, Polans AS (2007) Mitochondria, calcium, and calpain are Key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 72(6):1466-1475
65. Guo L, Peng Y, Yao J, Sui L, Gu A, Wang J (2010) Anticancer activity and molecular mechanism of resveratrol-bovine serum albumin nanoparticles on subcutaneously implanted human primary ovarian carcinoma cells in nude mice. Cancer Biother Radiopharm 25(4):471-477
66. Lee M-H, Choi BY, Kundu JK, Shin YK, Na H-K, Surh Y-J (2009) Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target. Cancer Res 69(18):7449-7458
67. Ganapathy S, Chen QH, Singh KP, Shankar S, Srivastava RK (2010) Resveratrol Enhances Antitumor Activity of TRAIL in Prostate Cancer Xenografts through Activation of FOXO Transcription Factor. PLoS One 5(12):e15627
68. Sheth S, Jajoo S, Kaur T, Mukherjea D, Sheehan K, Rybak LP et al (2012) Resveratrol reduces prostate cancer growth and metastasis by inhibiting the Akt/MicroRNA-21 pathway. PLoS One 7(12):e51655
69. Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, Pandey MK et al (2010) Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 127(2):257-268
70. Oi N, Jeong C-H, Nadas J, Cho Y-Y, Pugliese A, Bode AM et al (2010) Resveratrol, a Red wine polyphenol, suppresses pancreatic cancer by inhibiting leukotriene A4 hydrolase. Cancer Res 70(23):9755-9764
71. Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE, Zhang H (2013) In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev 14(3):1703-1706
72. Yu YH, Chen HA, Chen PS, Cheng YJ, Hsu WH, Chang YW et al (2013) MiR-520 h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Oncogene 32(4):431-443
73. Zhang M, Zhou X, Zhou K (2013) Resveratrol inhibits human nasopharyngeal carcinoma cell growth via blocking pAkt/p70S6K signaling pathways. Int J Mol Med 31(3):621-627
74. Tyagi A, Gu M, Takahata T, Frederick B, Agarwal C, Siriwardana S et al (2011) Resveratrol selectively induces DNA damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma. Clin Cancer Res 17(16):5402-5411
75. Yang Q, Wang B, Zang W, Wang X, Liu Z, Li W et al (2013) Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One 8(11):e70627
76. Hu F-W, Tsai L-L, Yu C-H, Chen P-N, Chou M-Y, Yu C-C (2012) Impairment of tumor-initiating stem-like property and reversal of epithelial-mesenchymal transdifferentiation in head and neck cancer by resveratrol treatment. Mol Nutr Food Res 56(8):1247-1258
77. Frampton GA, Lazcano EA, Li H, Mohamad A, DeMorrow S (2010) Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents. Lab Invest 90(9):1325-1338
78. Bai Y, Mao Q-Q, Qin J, Zheng X-Y, Wang Y-B, Yang K et al (2010) Resveratrol induces apoptosis and cell cycle arrest of human T24 bladder cancer cells in vitro and inhibits tumor growth in vivo. Cancer Sci 101(2):488-493
79. Majumdar APN, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J et al (2009) Curcumin synergizes with resveratrol to inhibit colon cancer. Nutr Cancer 61(4):544-553
80. Hao Y, Huang W, Liao M, Zhu Y, Liu H, Hao C et al (2013) The inhibition of resveratrol to human skin squamous cell carcinoma A431 xenografts in nude mice. Fitoterapia 86:84-91
81. Wang TT, Hudson TS, Wang TC, Remsberg CM, Davies NM, Takahashi Y et al (2008) Differential effects of resveratrol on androgen-responsive LNCaP human prostate cancer cells in vitro and in vivo. Carcinogenesis 29(10):2001-2010
82. Osmond GW, Masko EM, Tyler DS, Freedland SJ, Pizzo S (2013) In vitro and in vivo evaluation of resveratrol and 3,5-dihydroxy-4′-acetoxy-trans-stilbene in the treatment of human prostate carcinoma and melanoma. J Surg Res 179(1):e141-e148
83. Klink JC, Tewari AK, Masko EM, Antonelli J, Febbo PG, Cohen P et al (2013) Resveratrol worsens survival in SCID mice with prostate cancer xenografts in a cell-line specific manner, through paradoxical effects on oncogenic pathways. Prostate 73(7):754-762
84. Osmond GW, Augustine CK, Zipfel PA, Padussis J, Tyler DS (2012) Enhancing melanoma treatment with resveratrol. J Surg Res 172(1):109-115
85. Fukui M, Yamabe N, Kang KS, Zhu BT (2010) Growth-stimulatory effect of resveratrol in human cancer cells. Mol Carcinog 49(8):750-759
86. Zunino SJ, Storms DH, Newman JW, Pedersen TL, Keen CL, Ducore JM (2012) Dietary resveratrol does not delay engraftment, sensitize to vincristine or inhibit growth of high-risk acute lymphoblastic leukemia cells in NOD/SCID mice. Int J Oncol 41(6):2207-2212
87. Pan MH, Gao JH, Lai CS, Wang YJ, Chen WM, Lo CY et al (2008) Antitumor activity of 3,5,4′-trimethoxystilbene in COLO 205 cells and xenografts in SCID mice. Mol Carcinog 47(3):184-196
88. Hsieh TC, Huang YC, Wu JM (2011) Control of prostate cell growth, DNA damage and repair and gene expression by resveratrol analogues, in vitro. Carcinogenesis 32(1):93-101
89. Hsieh TC, Wong C, John Bennett D, Wu JM (2011) Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: an in silico and biochemical approach targeting integrin alphavbeta3. Int J Cancer 129(11):2732-2743
90. Roy P, Kalra N, Prasad S, George J, Shukla Y (2009) Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways. Pharm Res 26(1):211-217
91. Kai L, Samuel SK, Levenson AS (2010) Resveratrol enhances p53 acetylation and apoptosis in prostate cancer by inhibiting MTA1/NuRD complex. Int J Cancer 126(7):1538-1548
92. Wang TTY, Schoene NW, Kim YS, Mizuno CS, Rimando AM (2010) Differential effects of resveratrol and its naturally occurring methylether analogs on cell cycle and apoptosis in human androgen-responsive LNCaP cancer cells. Mol Nutr Food Res 54(3):335-344
93. Alex D, Leong EC, Zhang Z-J, Yan GTH, Cheng S-H, Leong C-W et al (2010) Resveratrol derivative, trans-3,5,4′-trimethoxystilbene, exerts antiangiogenic and vascular-disrupting effects in zebrafish through the downregulation of VEGFR2 and cell-cycle modulation. J Cell Biochem 109(2):339-346
94. Deck LM, Hunsaker LA, Gonzales AM, Orlando RA, Vander Jagt DL (2008) Substituted trans-stilbenes can inhibit or enhance the TPA-induced up-regulation of activator protein-1. BMC Pharmacol 8:19
95. Weng C-J, Wu C-F, Huang H-W, Wu C-H, Ho C-T, Yen G-C (2010) Evaluation of anti-invasion effect of resveratrol and related methoxy analogues on human hepatocarcinoma cells. J Agric Food Chem 58(5):2886-2894
96. Tsai J-H, Hsu L-S, Lin C-L, Hong H-M, Pan M-H, Way T-D et al (2013) 3,5,4′-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast cancer cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition. Toxicol Appl Pharmacol 272(3):746-756
97. Li K, Dias SJ, Rimando AM, Dhar S, Mizuno CS, Penman AD et al (2013) Pterostilbene acts through metastasis-associated protein 1 to inhibit tumor growth, progression and metastasis in prostate cancer. PLoS One 8(3):e57542
98. Kai L, Wang J, Ivanovic M, Chung Y-T, Laskin WB, Schulze-Hoepfner F et al (2011) Targeting prostate cancer angiogenesis through metastasis-associated protein 1 (MTA1). Prostate 71(3):268-280
99. Zheng LF, Wei QY, Cai YJ, Fang JG, Zhou B, Yang L et al (2006) DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship. Free Radic Biol Med 41(12):1807-1816
100. Basini G, Tringali C, Baioni L, Bussolati S, Spatafora C, Grasselli F (2010) Biological effects on granulosa cells of hydroxylated and methylated resveratrol analogues. Mol Nutr Food Res 54(S2):S236-S243
101. Son Y, Chung H-T, Pae H-O (2014) Differential effects of resveratrol and its natural analogs, piceatannol and 3,5,4′-trans-trimethoxystilbene, on anti-inflammatory heme oxigenase-1 expression in RAW264.7 macrophages. Biofactors 40(1):138-145
102. Rossi M, Caruso F, Antonioletti R, Viglianti A, Traversi G, Leone S et al (2013) Scavenging of hydroxyl radical by resveratrol and related natural stilbenes after hydrogen peroxide attack on DNA. Chem Biol Interact 206(2):175-185
103. Caruso F, Tanski J, Villegas-Estrada A, Rossi M (2004) Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem 52(24):7279-7285
104. Potter GA, Patterson LH, Wanogho E, Perry PJ, Butler PC, Ijaz T et al (2002) The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYPIBI. Br J Cancer 86(5):774-778
105. Piver B, Fer M, Vitrac X, Merillon J-M, Dreano Y, Berthou F et al (2004) Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes. Biochem Pharmacol 68(4):773-782